|
|||||
|
|
Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies |
|
| Authors: | Boris Grinshpun Nels Thorsteinson Joao NS Pereira Friedrich Rippmann David Nannemann Vanita D. Sood Yves Fomekong Nanfack |
| Affiliation: | aDiscovery & Development Technologies, Drug Disposition & Design, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA;bDepartment of Scientific Services, Chemical Computing Group ULC, Montreal, Quebec, Canada;cDiscovery & Development Technologies, Drug Disposition & Design, Merck Healthcare KGaA, Darmstadt, Germany |
| Abstract: | |
| Keywords: | |